--Myriad Genetics, Inc., a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer, effective May 1, 2025.

Learn more about Brian Donnelly, CFP a financial advisor in St. Peters, MO with the US News Advisor Finder.

Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer Provided by GlobeNewswire Apr 7, 2025 12:00pm. SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.

SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian ...